TrueBlue, Inc.
TBI · NYSE
6/29/2025 | 3/30/2025 | 12/31/2024 | 9/29/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 3.09 | -0.14 | -0.10 | 0.08 |
| FCF Yield | -8.30% | -16.99% | 0.34% | -5.43% |
| EV / EBITDA | 59.16 | -17.69 | -84.53 | 4,424.01 |
| Quality | ||||
| ROIC | -2.31% | -2.66% | -2.31% | -1.48% |
| Gross Margin | 23.61% | 23.32% | 26.57% | 24.34% |
| Cash Conversion Ratio | 73.71 | 1.54 | -0.52 | 0.93 |
| Growth | ||||
| Revenue 3-Year CAGR | -7.04% | -9.55% | -10.87% | -11.41% |
| Free Cash Flow Growth | 40.10% | -3,237.59% | 106.71% | -64.64% |
| Safety | ||||
| Net Debt / EBITDA | 18.53 | -6.53 | -12.72 | 762.06 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 41.22 | 41.19 | 37.47 | 44.48 |